ADMA Biologics, Inc. (ADMA)

ADMA Biologics Revenue

ADMA Biologics had revenue of $119.84M in the quarter ending September 30, 2024, with 78.13% growth. This brings the company's revenue in the last twelve months to $382.81M, up 63.39% year-over-year. In the year 2023, ADMA Biologics had annual revenue of $258.22M with 67.59% growth.

• Revenue (ttm): $382.81M
• Revenue Growth: +63.39%
• P/S Ratio: 12.75
• Revenue / Employee: $613,476
• Employees: 624
• Market Cap: 5.01B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	258.22M	104.13M	67.59%
Dec 31, 2022	154.08M	73.14M	90.36%
Dec 31, 2021	80.94M	38.72M	91.72%
Dec 31, 2020	42.22M	12.87M	43.85%
Dec 31, 2019	29.35M	12.36M	72.79%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.